Weight change with oral contraceptive use and during the menstrual cycle: Results of daily measurements

Contraception

Volumn 58, Issue 6, 1998, Pages 345-349

  Rosenberg, Michael ^a  

^a Health Decisions Inc   (United States)

Author keywords

Daily measurements; Oral contraceptive use; Weight change

Indexed keywords

ETHINYLESTRADIOL PLUS NORETHISTERONE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BODY WEIGHT DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MEASUREMENT; MENSTRUAL CYCLE; MONITORING; NORMAL HUMAN;

AMERICAS; BIOLOGY; BODY WEIGHT--WOMEN; CONTRACEPTION; CONTRACEPTIVE METHODS--SIDE EFFECTS; CORRELATION STUDIES; DEVELOPED COUNTRIES; FAMILY PLANNING; MENSTRUAL CYCLE; MENSTRUATION; NORTH AMERICA; NORTHERN AMERICA; ORAL CONTRACEPTIVES, COMBINED--SIDE EFFECTS; ORAL CONTRACEPTIVES, PHASIC--SIDE EFFECTS; ORAL CONTRACEPTIVES--SIDE EFFECTS; PHYSIOLOGY; REPRODUCTION; RESEARCH METHODOLOGY; RESEARCH REPORT; STATISTICAL STUDIES; STUDIES; UNITED STATES; WOMEN;

ADOLESCENT; ADULT; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; MENSTRUAL CYCLE; TIME FACTORS; WEIGHT GAIN;

EID: 0032464936     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(98)00127-9     Document Type: Article

References (10)

1. 1. Pratt WF, Bachrach CA. What do women use when they stop using the pill? Fam Plann Perspect 1987; 19(suppl 6):257-66.
2. 2. Rosenberg MJ, Waugh MS, Meehan TE. Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation. Contraception 1995;51:283-8.
3. 3. Serfaty D. Oral contraceptive compliance during adolescence. Ann NY Acad Sci 1997;816:422-431.
4. 4. Reubinoff BE, Grubstein A, Meirow D, et al. Effects of low-dose estrogen oral contraceptives on weight, body composition, and fat distribution in young women. Fertil Steril 1995;63:516-21.
5. 5. Bannemerschult R, Hanker JP, Wunsch C, et al. A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 μg ethinyl estradiol and 100 μg levonorgestrel over six treatment cycles. Contraception 1997;56:285-90.
6. 6. Carpenter S, Neinstein LS. Weight gain in adolescent and young oral contraceptive users. J Adolesc Hlth Care 1986;7:342-4.
7. 7. Woutersz TB, Korba VD. Five-year, multicenter study of a triphasic, low-dose, combination oral contraceptive. Int J Fertil 1988;33:406-10.
8. 8. Moore L, Valuck R, McDougall C, Fink W. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives. Contraception 1995; 52:215-20.
9. 9. Goldzieher JW, Moses LE, Averkin E, et al. A placebo-controlled double-blind crossover investigation of the side effects attributed to oral contraceptives. Fertil Steril 1971;22:609-23.
10. 10. Diffey B, Liers LS, Soares MJ, O'Dea K. The effect of oral contraceptive agents on the basal metabolic rate of young women. Br J Nutr 1997;77:853-62.